Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Michael Berger, MD
Woman and Man Max 99 years
Michael Berger, MD
Update Il y a 4 ans
Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match Alternative to Allogeneic Transplant for Blood Cancers
This phase I/II clinical investigation is designed to determine the safety and anti-tumor effects of intravenous administration of the experimental immunotherapy drug, called AlloStim. The...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Michael Berger, MD
Update Il y a 4 ans
In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation
This is a Phase I/II study to investigate the feasibility of creating a personalized therapeutic cancer vaccine within the body. A vaccine contains a source of tumor antigen and an adjuvan...
Country
None
organs
None
Specialty
None
Closed trial
More information